Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases

No abstract is available for this paper.

• Publication year

  2012

• Venue

  BioDrugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00063030-200721010-00007PMID 17263590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

  2005cited by this paper
• Probiotic Therapy in the Prevention of Pouchitis Onset: Decreased Interleukin‐1&bgr;, Interleukin‐8, and Interferon‐&ggr; Gene Expression

  2005cited by this paper
• Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.

  2005cited by this paper
• Modulation of human dendritic cell phenotype and function by probiotic bacteria

  2004cited by this paper
• Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

  2004cited by this paper
• Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

  2004cited by this paper
• DNA from probiotic bacteria modulates murine and human epithelial and immune function.

  2004cited by this paper
• Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

  2003cited by this paper
• PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption.

  2003cited by this paper
• Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.

  2003cited by this paper
• Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment

  2001cited by this paper
• Behaviour of the pharmaceutical probiotic preparation VSL#3 in human ileostomy effluent containing its own natural elements.

  2001cited by this paper
• Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial

  2000cited by this paper
• Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

  1999cited by this paper
• Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis

  1999cited by this paper

• Microbiota-Driven Strategies for Managing IBD-Associated Risks: From Infections to Mental Health

  2026cites this paper
• Probiotics and the intestinal tight junction barrier function

  2025cites this paper
• New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites

  2025cites this paper
• Probiotics intervention for type 2 diabetes mellitus therapy: a review from proposed mechanisms to future prospects

  2024cites this paper
• Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models

  2023cites this paper
• Current vision on diagnosis and comprehensive care in hepatic encephalopathy.

  2023cites this paper
• Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022

  2023cites this paper
• Multi-strain probiotics combined with fruit-vegetable powders for regulating intestinal inflammation and intestinal epithelial barrier

  2022cites this paper
• Anti-inflammatory and Immunomodulatory Potency of Selenium-Enriched Probiotic Mutants in Mice with Induced Ulcerative Colitis

  2022cites this paper
• Natural compounds as safe therapeutic options for ulcerative colitis

  2022cites this paper
• Probiotics, prebiotics and symbiotics attenuate chronic effects of passive smoking on physiological and biochemical parameters in rats: A randomized and controlled study

  2021cites this paper
• Novel Therapies in Hepatic Encephalopathy.

  2020cites this paper
• 3 Drug Therapy in Ulcerative Colitis

  2018cites this paper
• Organoids, organs-on-chips and other systems, and microbiota

  2017cites this paper
• [Probiotics: innocuousness, prevention and risks].

  2017cites this paper
• Common Organisms and Probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus)

  2017cites this paper
• Beneficial Influences of Lactobacillus plantarum on Human Health and Disease

  2017cites this paper
• Lactobacilli possess inhibitory activity against dipeptidyl peptidase-4 (DPP-4)

  2016influential citation
• Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential

  2014cites this paper
• Probiotics for the treatment of Clostridium difficile associated disease.

  2013cites this paper
• Exploring the ameliorative potential of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulphate induced colitis in mice

  2013cites this paper
• Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis.

  2013cites this paper
• Investigating the role of intestinal microflora in the aetiology, symptom scores and life quality of people with coeliac disease

  2013cites this paper
• The role of bacterial infection in the aetiology of the overactive bladder

  2012cites this paper
• Probiotic Bacteria Regulate Intestinal Epithelial Permeability in Experimental Ileitis by a TNF-Dependent Mechanism

  2012cites this paper
• Impact of antibiotic use, alternative therapies and inflammation on the intestinal microbiota

  2012cites this paper
• The Role of the Microbiota in Gastrointestinal Health and Disease

  2012cites this paper
• Chapter 14 – Probiotics and Prebiotics: Effects on Diarrhea

  2010cites this paper
• Reconstitution conditions for dried probiotic powders represent a critical step in determining cell viability

  2010cites this paper
• Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

  2010cites this paper
• Current therapeutic approaches in inflammatory bowel disease.

  2010cites this paper
• Probiotics and Iletis

  2010cites this paper
• Effects of Live and Inactivated VSL#3 Probiotic Preparations in the Modulation of in vitro and in vivo Allergen-Induced Th2 Responses

  2009cites this paper
• Site and Clinical Significance of Alloscardovia omnicolens and Bifidobacterium Species Isolated in the Clinical Laboratory

  2009cites this paper
• Therapeutic effects of four strains of probiotics on experimental colitis in mice.

  2009cites this paper
• Pouchitis: An Evolving Clinical Enigma-A Review

  2009cites this paper
• Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

  2008cites this paper
• Probiotics Regulate the Expression of COX-2 in Intestinal Epithelial Cells

  2008cites this paper